What should I do if my blood sugar drops below 4 mmol/L while on incretin mimetics
Limiti dei dati di sicurezza: La principale limitazione riguarda la mancanza di dati di sicurezza a lungo termine nell'uomo
Between January 1, 2023, and November 26, 2024, researchers enrolled 1,407 adults with obesity (BMI 30 kg/m) without diabetes, randomly assigning participants to receive semaglutide 7.2 mg (n=1,005), semaglutide 2.4 mg (n=201), or placebo (n=201). The study population was predominantly female with a mean age of 47 years, mean body weight of 113 kg, and BMI of approximately 40 kg/m
Monitoring Blood glucose levels A1C testing Weight changes Symptoms of pancreatitis or thyroid issues Who This Medication Is For Semaglutide is prescribed for: Adults with type 2 diabetes needing improved blood sugar control Adults with type 2 diabetes and established cardiovascular disease Adults with obesity or overweight with related health conditions (depending on formulation approval) It is intended for chronic management under medical supervision